SelSym Biotech is developing innovative therapeutics for addressing critical clinical needs to transform patient care and outcomes in the areas of hemorrhage control, surgical bleeding, and wound healing.
Our Mission
Our Team
EXECUTIVE & DEVELOPMENT TEAM
Seema Nandi, PhD
Co-Founder | CEO
Andrew Lyon, PhD
Co-Founder | Chief Scientific Officer
Ashley Brown, PhD
Co-Founder | Senior Scientific Advisor
Tom Barker, PhD
Co-Founder | President
OUR STORY
SelSym: Revolutionizing Hemorrhage Control
Like so many innovations, the ideas that launched SelSym Biotech emerged over a few cups of coffee and some furious scribbling on napkins. Those conversations led to a remarkable collaboration between ambitious scientists, engineers, and clinicians – all of whom were driven to address the key unmet clinical needs in trauma and hemorrhage treatment and management. Now more than a decade later, those ideas have become the foundation of SelSym’s Hemostatic Healing Hydrogel technology, which holds tremendous promise in transforming the care of traumatic injury and post-surgical bleeding.